Behavidence Closes $4.3M Seed Funding
- Behavidence, a NYC-based provider of tools to monitor psychiatric and neurological disorders using artificial intelligence, raised $4.3M in Seed funding
- The round was led by Welltech Ventures, with participation from Arc Impact and Longevity Ventures
- The company intends to use the funds to develop its machine learning-based tools
- The company develops machine learning based tools to detect and assist with remote monitoring and management of mental health conditions
- The company has secured more than $1 million in contracts with customers across the United States, Europe, Africa and Asia
- Its clients include the Department of Veterans Affairs, Discovery Health Insurance and Essen Health Care
